{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:15:35Z","timestamp":1788909335257,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Klinikum der Universit\u00e4t M\u00fcnchen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>It is unclear whether the age-related decline in the somatotropic axis stems from a reduced growth hormone (GH) production in the pituitary gland, or from a peripheral origin akin to an acquired GH resistance. With the help of a GHRH\/arginine test, high-aged multimorbid hospitalized patients with IGF-I deficiency are to be tested to determine whether there is primarily a pituitary GH deficiency in the sense of a somatopause.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Seventeen multimorbid patients (eleven men and six women) with a mean age of 82 years, with IGF-I concentrations below two standard deviations of 30-year-old men and women were identified. Patients suffered from a variety of common age-related stable diseases including coronary artery disease, chronic liver or kidney disease, chronic heart failure as well as acute conditions e.g., urosepsis or endocarditis. To assess the somatotropic axis they underwent a GHRH\/arginine test. Results were evaluated using descriptive statistics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In average, the peak concentration of GH after stimulation was 14.8\u00a0\u00b5g\/L with a range from 2.76 to 47.4\u00a0\u00b5g\/L. Taking into account both, gender and BMI (with a mean of 26.5\u00a0kg\/m\u00b2) for each participant, the pituitary gland was adequately stimulated in 16 out of the 17 patients. No patient reported common side effects related to the GHRH\/arginine test.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The somatotroph pituitary gland retains its secretory capacity in the advanced aged. Therefore, age does not seem to be the driving pacemaker for the functional decline of the somatotropic axis within the aged population.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11102-024-01406-y","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T06:01:53Z","timestamp":1717135313000},"page":"480-487","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The somatotroph pituitary gland function in high-aged multimorbid hospitalized patients with IGF-I deficiency"],"prefix":"10.1007","volume":"27","author":[{"given":"Olivia","family":"Tausendfreund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bidlingmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Reif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Rippl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Schilbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Schmidmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Drey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,31]]},"reference":[{"key":"1406_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ecl.2022.10.003","volume":"52","author":"C Hage","year":"2023","unstructured":"Hage C, Salvatori R (2023) Growth hormone and aging. Endocrinol Metab Clin North Am 52:245\u2013257. https:\/\/doi.org\/10.1016\/j.ecl.2022.10.003","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1406_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ecl.2012.04.017","volume":"41","author":"DR Clemmons","year":"2012","unstructured":"Clemmons DR (2012) Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes. Endocrinol Metab Clin North Am 41:425\u2013443 vii\u2013viii. https:\/\/doi.org\/10.1016\/j.ecl.2012.04.017","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1406_CR3","doi-asserted-by":"publisher","first-page":"1142644","DOI":"10.3389\/fendo.2023.1142644","volume":"14","author":"M Macvanin","year":"2023","unstructured":"Macvanin M, Gluvic Z, Radovanovic J et al (2023) New insights on the cardiovascular effects of IGF-1. Front Endocrinol (Lausanne) 14:1142644","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1406_CR4","first-page":"103","volume":"32","author":"J Isgaard","year":"2007","unstructured":"Isgaard J, Aberg D, Nilsson M (2007) Protective and regenerative effects of the GH\/IGF-I axis on the brain. Minerva Endocrinol 32:103\u2013113","journal-title":"Minerva Endocrinol"},{"key":"1406_CR5","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1186\/s12891-021-04699-3","volume":"22","author":"S Jarmusch","year":"2021","unstructured":"Jarmusch S, Baber L, Bidlingmaier M et al (2021) Influence of IGF-I serum concentration on muscular regeneration capacity in patients with Sarcopenia. BMC Musculoskelet Disord 22:807. https:\/\/doi.org\/10.1186\/s12891-021-04699-3","journal-title":"BMC Musculoskelet Disord"},{"key":"1406_CR6","first-page":"94","volume":"28","author":"R Giordano","year":"2005","unstructured":"Giordano R, Lanfranco F, Bo M et al (2005) Somatopause reflects age-related changes in the neural control of GH\/IGF-I axis. J Endocrinol Invest 28:94\u201398","journal-title":"J Endocrinol Invest"},{"key":"1406_CR7","first-page":"243","volume":"36","author":"C Di Somma","year":"2011","unstructured":"Di Somma C, Brunelli V, Savanelli MC et al (2011) Somatopause: state of the art. Minerva Endocrinol 36:243\u2013255","journal-title":"Minerva Endocrinol"},{"key":"1406_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11556-007-0022-1","volume":"4","author":"S Moran","year":"2007","unstructured":"Moran S, Chen Y, Ruthie A, Nir Y (2007) Alterations in IGF-I affect elderly: role of physical activity. Eur Rev Aging Phys Activity 4:77\u201384. https:\/\/doi.org\/10.1007\/s11556-007-0022-1","journal-title":"Eur Rev Aging Phys Activity"},{"key":"1406_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ejphar.2004.02.047","volume":"490","author":"PS van Dam","year":"2004","unstructured":"van Dam PS, Aleman A (2004) Insulin-like growth factor-I, cognition and brain aging. Eur J Pharmacol 490:87\u201395. https:\/\/doi.org\/10.1016\/j.ejphar.2004.02.047","journal-title":"Eur J Pharmacol"},{"key":"1406_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16\u201331. https:\/\/doi.org\/10.1093\/ageing\/afy169","journal-title":"Age Ageing"},{"key":"1406_CR11","doi-asserted-by":"publisher","first-page":"e1698","DOI":"10.1210\/clinem\/dgaa972","volume":"106","author":"U Ferrari","year":"2021","unstructured":"Ferrari U, Schmidmaier R, Jung T et al (2021) IGF-I\/IGFBP3\/ALS Deficiency in Sarcopenia: low GHBP suggests GH Resistance in a subgroup of geriatric patients. J Clin Endocrinol Metab 106:e1698\u2013e1707. https:\/\/doi.org\/10.1210\/clinem\/dgaa972","journal-title":"J Clin Endocrinol Metab"},{"key":"1406_CR12","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1210\/jc.2013-3059","volume":"99","author":"M Bidlingmaier","year":"2014","unstructured":"Bidlingmaier M, Friedrich N, Emeny RT et al (2014) Reference intervals for insulin-like growth factor-1 (igf-i) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations. J Clin Endocrinol Metab 99:1712\u20131721. https:\/\/doi.org\/10.1210\/jc.2013-3059","journal-title":"J Clin Endocrinol Metab"},{"key":"1406_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1530\/EJE-16-0668","volume":"176","author":"T Deutschbein","year":"2017","unstructured":"Deutschbein T, Bidlingmaier M, Schopohl J et al (2017) Anthropometric factors have signifcant influence on the outcome of the GHRH-arginine test: establishment of normative data for an automated immunoassay specifcally measuring 22\u00a0kDa human growth hormone. Eur J Endocrinol 176:273\u2013281. https:\/\/doi.org\/10.1530\/EJE-16-0668","journal-title":"Eur J Endocrinol"},{"key":"1406_CR14","doi-asserted-by":"publisher","first-page":"618","DOI":"10.20945\/2359-3997000000192","volume":"63","author":"K Schilbach","year":"2019","unstructured":"Schilbach K, Bidlingmaier M (2019) Laboratory investigations in the diagnosis and follow-up of GH-related disorders. Arch Endocrinol Metab 63:618\u2013629. https:\/\/doi.org\/10.20945\/2359-3997000000192","journal-title":"Arch Endocrinol Metab"},{"key":"1406_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1023\/a:1015306705154","volume":"4","author":"G Aimaretti","year":"2001","unstructured":"Aimaretti G, Bellone S, Baffoni C et al (2001) Short procedure of GHRH plus arginine test in clinical practice. Pituitary 4:129\u2013134. https:\/\/doi.org\/10.1023\/a:1015306705154","journal-title":"Pituitary"},{"key":"1406_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ghir.2007.07.004","volume":"18","author":"E Ghigo","year":"2008","unstructured":"Ghigo E, Aimaretti G, Corneli G (2008) Diagnosis of adult GH deficiency. Growth Horm IGF Res 18:1\u201316. https:\/\/doi.org\/10.1016\/j.ghir.2007.07.004","journal-title":"Growth Horm IGF Res"},{"key":"1406_CR17","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1373\/clinchem.2012.188128","volume":"58","author":"J Manolopoulou","year":"2012","unstructured":"Manolopoulou J, Alami Y, Petersenn S et al (2012) Automated 22-kD growth hormone\u2013specific assay without interference from Pegvisomant. Clin Chem 58:1446\u20131456. https:\/\/doi.org\/10.1373\/clinchem.2012.188128","journal-title":"Clin Chem"},{"key":"1406_CR18","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1007\/S12603-009-0214-7","volume":"13","author":"MJ Kaiser","year":"2009","unstructured":"Kaiser MJ, Bauer JM, Ramsch C et al (2009) Validation of the Mini Nutritional Assessment short-form (MNA-SF): a practical tool for identification of nutritional status. J Nutr Health Aging 13:782\u2013788. https:\/\/doi.org\/10.1007\/S12603-009-0214-7","journal-title":"J Nutr Health Aging"},{"key":"1406_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3109\/09638288809164103","volume":"10","author":"C Collin","year":"1988","unstructured":"Collin C, Wade DT, Davies S, Horne V (1988) The Barthel ADL Index: a reliability study. Int Disabil Stud 10:61\u201363. https:\/\/doi.org\/10.3109\/09638288809164103","journal-title":"Int Disabil Stud"},{"key":"1406_CR20","doi-asserted-by":"publisher","first-page":"e220504","DOI":"10.1530\/EC-22-0504","volume":"12","author":"KCJ Yuen","year":"2023","unstructured":"Yuen KCJ, Johannsson G, Ho KKY et al (2023) Diagnosis and testing for growth hormone deficiency across the ages: a global view of the accuracy, caveats, and cut-offs for diagnosis. Endocr Connect 12:e220504. https:\/\/doi.org\/10.1530\/EC-22-0504","journal-title":"Endocr Connect"},{"key":"1406_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrendo.2013.38","volume":"9","author":"JD Veldhuis","year":"2013","unstructured":"Veldhuis JD (2013) Changes in pituitary function with ageing and implications for patient care. Nat Rev Endocrinol 9:205\u2013215. https:\/\/doi.org\/10.1038\/nrendo.2013.38","journal-title":"Nat Rev Endocrinol"},{"key":"1406_CR22","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1210\/jc.2012-2481","volume":"97","author":"AC Waring","year":"2012","unstructured":"Waring AC, Arnold AM, Newman AB et al (2012) Longitudinal changes in thyroid function in the Oldest Old and Survival: the Cardiovascular Health Study All-Stars Study. J Clin Endocrinol Metab 97:3944\u20133950. https:\/\/doi.org\/10.1210\/jc.2012-2481","journal-title":"J Clin Endocrinol Metab"},{"key":"1406_CR23","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1001\/jama.292.21.2591","volume":"292","author":"J Gussekloo","year":"2004","unstructured":"Gussekloo J (2004) Thyroid status, disability and cognitive function, and Survival in Old Age. JAMA 292:2591. https:\/\/doi.org\/10.1001\/jama.292.21.2591","journal-title":"JAMA"},{"key":"1406_CR24","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.4158\/EP14003.OR","volume":"20","author":"KF Almoosa","year":"2014","unstructured":"Almoosa KF, Gupta A, Pedroza C, Watts NB (2014) Low testosterone levels are frequent in patients with Acute Respiratory failure and are Associated with poor outcomes. Endocr Pract 20:1057\u20131063. https:\/\/doi.org\/10.4158\/EP14003.OR","journal-title":"Endocr Pract"},{"key":"1406_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ghir.2018.03.005","volume":"40","author":"K Schilbach","year":"2018","unstructured":"Schilbach K, Olsson DS, Boguszewski MCS et al (2018) Biomarkers of GH action in children and adults. Growth Horm IGF Res 40:1\u20138. https:\/\/doi.org\/10.1016\/j.ghir.2018.03.005","journal-title":"Growth Horm IGF Res"},{"key":"1406_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/bf03340148","volume":"9","author":"E Kurtis","year":"1997","unstructured":"Kurtis E (1997) Function of GH\/IGF-I axis in aging: Multicenter study in 152 healthy elderly subjects with different degrees of physical activity. Aging Clin Exp Res 9:185\u2013192. https:\/\/doi.org\/10.1007\/bf03340148","journal-title":"Aging Clin Exp Res"},{"key":"1406_CR27","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1210\/jcem-71-6-1481","volume":"71","author":"E GHIGO","year":"1990","unstructured":"Ghigo E, Goffi S, Nicolosi M et al (1990) Growth hormone (GH) responsiveness to Combined Administration of Arginine and GH-Releasing hormone does not vary with age in Man*. J Clin Endocrinol Metab 71:1481\u20131485. https:\/\/doi.org\/10.1210\/jcem-71-6-1481","journal-title":"J Clin Endocrinol Metab"},{"key":"1406_CR28","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrendo.2013.77","volume":"9","author":"AY Kargi","year":"2013","unstructured":"Kargi AY, Merriam GR (2013) Diagnosis and treatment of growth hormone deficiency in adults. Nat Rev Endocrinol 9:335\u2013345. https:\/\/doi.org\/10.1038\/nrendo.2013.77","journal-title":"Nat Rev Endocrinol"},{"key":"1406_CR29","doi-asserted-by":"publisher","unstructured":"Jaul E, Barron J (2017) Age-Related diseases and Clinical and Public Health Implications for the 85 Years Old and Over Population. Front Public Health 5. https:\/\/doi.org\/10.3389\/fpubh.2017.00335","DOI":"10.3389\/fpubh.2017.00335"},{"key":"1406_CR30","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1530\/EJE-10-1068","volume":"164","author":"F Bogazzi","year":"2011","unstructured":"Bogazzi F, Manetti L, Lombardi M et al (2011) Impact of different cut-off limits of peak GH after GHRH-arginine stimulatory test, single IGF1 measurement, or their combination in identifying adult patients with GH deficiency. Eur J Endocrinol 164:685\u2013693. https:\/\/doi.org\/10.1530\/EJE-10-1068","journal-title":"Eur J Endocrinol"},{"key":"1406_CR31","doi-asserted-by":"publisher","first-page":"M124","DOI":"10.1093\/gerona\/56.2.m124","volume":"56","author":"M Russell-Aulet","year":"2001","unstructured":"Russell-Aulet M, Dimaraki EV, Jaffe CA et al (2001) Aging-related growth hormone (GH) decrease is a selective hypothalamic GH-releasing hormone pulse amplitude mediated phenomenon. J Gerontol Biol Sci Med Sci 56:M124\u2013M129. https:\/\/doi.org\/10.1093\/gerona\/56.2.m124","journal-title":"J Gerontol Biol Sci Med Sci"},{"key":"1406_CR32","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1210\/jcem-64-5-884","volume":"64","author":"A VERMEULEN","year":"1987","unstructured":"Vermeulen A (1987) Nyctohemeral Growth hormone profiles in Young and aged men: correlation with Somatomedin-C Levels*. J Clin Endocrinol Metab 64:884\u2013888. https:\/\/doi.org\/10.1210\/jcem-64-5-884","journal-title":"J Clin Endocrinol Metab"},{"key":"1406_CR33","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1210\/jcem-60-3-513","volume":"60","author":"ZVI ZADIK","year":"1985","unstructured":"Zadik ZVI, Chalew A, McCarter JR. RJ et al (1985) The influence of age on the 24-Hour Integrated concentration of growth hormone in normal Individuals*. J Clin Endocrinol Metab 60:513\u2013516. https:\/\/doi.org\/10.1210\/jcem-60-3-513","journal-title":"J Clin Endocrinol Metab"},{"key":"1406_CR34","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1210\/jc.2003-031033","volume":"89","author":"Z Laron","year":"2004","unstructured":"Laron Z (2004) Laron Syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958\u20132003. J Clin Endocrinol Metab 89:1031\u20131044. https:\/\/doi.org\/10.1210\/jc.2003-031033","journal-title":"J Clin Endocrinol Metab"},{"key":"1406_CR35","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1054\/jcaf.2003.23","volume":"9","author":"M Cicoira","year":"2003","unstructured":"Cicoira M, Kalra PR, Anker SD (2003) Growth hormone resistance in chronic heart failure and its therapeutic implications. J Card Fail 9:219\u2013226. https:\/\/doi.org\/10.1054\/jcaf.2003.23","journal-title":"J Card Fail"},{"key":"1406_CR36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/s0950-351x(98)80025-6","volume":"12","author":"RC Jenkins","year":"1998","unstructured":"Jenkins RC, Ross RJ (1998) Acquired growth hormone resistance in adults. Baillieres Clin Endocrinol Metab 12:315\u2013329. https:\/\/doi.org\/10.1016\/s0950-351x(98)80025-6","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"1406_CR37","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1089\/107999003321829944","volume":"23","author":"A Picardi","year":"2003","unstructured":"Picardi A, Gentilucci UV, Zardi EM et al (2003) TNF-alpha and growth hormone resistance in patients with chronic liver disease. J Interferon Cytokine Res 23:229\u2013235. https:\/\/doi.org\/10.1089\/107999003321829944","journal-title":"J Interferon Cytokine Res"},{"key":"1406_CR38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40618-015-0327-2","volume":"39","author":"S Kurto\u011flu","year":"2016","unstructured":"Kurto\u011flu S, Hatipoglu N (2016) Growth hormone insensitivity: diagnostic and therapeutic approaches. J Endocrinol Invest 39:19\u201328. https:\/\/doi.org\/10.1007\/s40618-015-0327-2","journal-title":"J Endocrinol Invest"},{"key":"1406_CR39","doi-asserted-by":"publisher","unstructured":"Adamek A, Kasprzak A (2018) Insulin-like growth factor (IGF) system in Liver diseases. Int J Mol Sci 19. https:\/\/doi.org\/10.3390\/ijms19051308","DOI":"10.3390\/ijms19051308"},{"key":"1406_CR40","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00467-007-0527-x","volume":"23","author":"S Mahesh","year":"2008","unstructured":"Mahesh S, Kaskel F (2008) Growth hormone axis in chronic kidney disease. Pediatr Nephrol 23:41\u201348. https:\/\/doi.org\/10.1007\/s00467-007-0527-x","journal-title":"Pediatr Nephrol"},{"key":"1406_CR41","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/ki.2008.345","volume":"74","author":"G Garibotto","year":"2008","unstructured":"Garibotto G, Russo R, Sofia A et al (2008) Effects of Uremia and inflammation on growth hormone resistance in patients with chronic kidney diseases. Kidney Int 74:937\u2013945. https:\/\/doi.org\/10.1038\/ki.2008.345","journal-title":"Kidney Int"},{"key":"1406_CR42","doi-asserted-by":"publisher","first-page":"E63","DOI":"10.1152\/ajpendo.00555.2002","volume":"285","author":"LQ Hong-Brown","year":"2003","unstructured":"Hong-Brown LQ, Brown CR, Cooney RN et al (2003) Sepsis-induced muscle growth hormone resistance occurs independently of STAT5 phosphorylation. Am J Physiol Endocrinol Metab 285:E63\u201372. https:\/\/doi.org\/10.1152\/ajpendo.00555.2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1406_CR43","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/S0140-6736(97)11329-0","volume":"351","author":"KJ Osterziel","year":"1998","unstructured":"Osterziel KJ, Strohm O, Schuler J et al (1998) Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet 351:1233\u20131237. https:\/\/doi.org\/10.1016\/S0140-6736(97)11329-0","journal-title":"Lancet"},{"key":"1406_CR44","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0735-1097(01)01385-7","volume":"38","author":"SD Anker","year":"2001","unstructured":"Anker SD, Volterrani M, Pflaum CD et al (2001) Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. J Am Coll Cardiol 38:443\u2013452. https:\/\/doi.org\/10.1016\/S0735-1097(01)01385-7","journal-title":"J Am Coll Cardiol"},{"key":"1406_CR45","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1053\/euhj.1998.1123","volume":"19","author":"J Isgaard","year":"1998","unstructured":"Isgaard J, Bergh CH, Caidahl K et al (1998) A placebo-controlled study of growth hormone in patients with congestive heart failure. Eur Heart J 19:1704\u20131711. https:\/\/doi.org\/10.1053\/euhj.1998.1123","journal-title":"Eur Heart J"},{"key":"1406_CR46","doi-asserted-by":"publisher","first-page":"76s","DOI":"10.1183\/09031936.03.00004610","volume":"46","author":"EC Creutzberg","year":"2003","unstructured":"Creutzberg EC, Casaburi R (2003) Endocrinological disturbances in chronic obstructive pulmonary disease. Eur Respir J Suppl 46:76s\u201380s. https:\/\/doi.org\/10.1183\/09031936.03.00004610","journal-title":"Eur Respir J Suppl"},{"key":"1406_CR47","doi-asserted-by":"publisher","first-page":"101584","DOI":"10.1016\/j.ghir.2024.101584","volume":"75","author":"O Tausendfreund","year":"2024","unstructured":"Tausendfreund O, Bidlingmaier M, Martini S et al (2024) Growth hormone treatment in aged patients with comorbidities: a systematic review. Growth Hormon IGF Res 75:101584. https:\/\/doi.org\/10.1016\/j.ghir.2024.101584","journal-title":"Growth Hormon IGF Res"},{"key":"1406_CR48","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1210\/er.2018-00216","volume":"40","author":"MH Aguiar-Oliveira","year":"2019","unstructured":"Aguiar-Oliveira MH, Bartke A (2019) Growth hormone Deficiency: Health and Longevity. Endocr Rev 40:575\u2013601. https:\/\/doi.org\/10.1210\/er.2018-00216","journal-title":"Endocr Rev"},{"key":"1406_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/joe.0.1410001","volume":"141","author":"G Baumann","year":"1994","unstructured":"Baumann G (1994) Growth hormone-binding proteins: state of the art. J Endocrinol 141:1\u20136. https:\/\/doi.org\/10.1677\/joe.0.1410001","journal-title":"J Endocrinol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01406-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-024-01406-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01406-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T04:55:45Z","timestamp":1730868945000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-024-01406-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,31]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1406"],"URL":"https:\/\/doi.org\/10.1007\/s11102-024-01406-y","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,31]]},"assertion":[{"value":"17 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Ethics committee of the Medical Faculty of Ludwig-Maximilians-University (LMU) Munich, Germany (vote no. 23\u20130981), as well as the registry inclusion (Ethical vote no.17\u2013874). Written informed consent was obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}